The invention relates to the therapeutic use of novel stabilizedoligoribonucleotides as immune modulatory agentsfor immune therapy applications. Specifically, the invention provides novelRNA-based oligoribonucleotides with improved nucleaseand RNase stability and that have immune modulatory activity through TLR7and/or TLR8.